IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

TC Biopharm Holdings PLC

Q3 2024 vs Q4 2024

Comparing institutional holders between quarters

Quarters

Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile
Rhumbline Advisers
UNCHANGED
Shares83 from 83
Change0 (0%)
Value$53 (-$386)
Filed 2025-05-29
Status
Rhumbline Advisers
UNCHANGED838300%$439$53-$3862025-05-29
Showing 1 of 1 institutions